Multidetector CT without oral contrast can be effective on larger patients presenting with acute abdominal pain.
Contrast is not needed for all patients undergoing multidetector CT (MDCT) for investigation of acute abdominal pain in the emergency room, according to a study published in the Canadian Association of Radiologists Journal.
Researchers from Canada performed a retrospective study to determine if eliminating oral contrast for MDCT affected the detection of acute abdominal abnormalities in patients presenting to the ER.
A total of 375 patients were included in the study, which took place from November 1, 2102 to October 21, 2013. There were 174 males and 201 females, with a mean age of 57. All patients presented with complaints of acute abdominal pain, and their body mass index was above 25. Patients who had BMI of less than 25 were given the oral contrast.[[{"type":"media","view_mode":"media_crop","fid":"43479","attributes":{"alt":"oral contrast","class":"media-image media-image-right","id":"media_crop_2989958619925","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"4745","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 100px; width: 100px; border-width: 0px; border-style: solid; margin: 1px; float: right;","title":"©Mr Aesthetics/Shutterstock.com","typeof":"foaf:Image"}}]]
The results showed that seven of 375 (1.9%) of the patients required a repeat CT examination with oral contrast within seven days of their initial scan, although none of these patients required a change in the course of their management following the scan with the oral contrast. No delayed or missed diagnoses related to the absence of oral contrast were identified.
The authors concluded that patients with a BMI over 25 who presented to the ER with acute abdominal pain did not require oral contrast for MDCT, which allows for quicker screening.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.